FDA advises on drug naming; Novavax seeks new flu vax partner for Spain;

> New FDA guidance advises drugmakers on the creation of proprietary drug names to minimize medication errors. Guidance

> Novavax has discontinued its deal with ROVI Pharmaceuticals to develop the former's influenza vaccine for Spain. Release

> As the camera film business continues its decline, Kodak is using its manufacturing operations and expertise to produce gels for the pharma industry as well as inks and dyes for personal-care products. Article

> Regis Technologies of Morton Grove, IL, has passed the FDA's pre-approval inspection for its manufacture of the active ingredient in multiple sclerosis drug Ampyra, approved last month. Release

> Sweden's Medical Products Agency is proposing that an environmental certification for pharmaceutical production facilities be introduced into Good Manufacturing Practice requirements. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.